CFDB - Cystic Fibrosis DataBase

primary studies published RCT

A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.

Study design (if review, criteria of inclusion for studies)

phase III multicenter vaccine trial using the Pseudomonas aeruginosa 5142/1210-Flagella Vaccine IMMUNO was initiated. placebo-controlled, randomized and double-blind design.

Participants

400 CF patients without P. aeruginosa lung infection m 16 CF centers in Germany, France and Italy.

Keywords: Adult; Bacterial Infections; Immunization; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Infection; pharmacological_intervention; Pseudomonas aeruginosa; Pseudomonas; Respiratory Tract Diseases; Respiratory Tract Infections; Immunoglobulins;